Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended-release (XR) venlafaxine appears effective in the prevention of migraine and CTTH

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet

By Wei Qionghua   Yang Feifei   Luan Libiao  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 6, 2013-06 ,pp. : 928-934

Informa Healthcare

Access to resources Recommend Favorite

Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction

By Qandil Amjad  

Journal of Pharmaceutical Investigation, Vol. 43, Iss. 3, 2013-06 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite